ADVISORY RESEARCH INC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 207 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
ADVISORY RESEARCH INC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$991,000
+14.8%
20,439
+0.0%
0.09%
+46.7%
Q1 2020$863,000
+1.2%
20,434
+2.4%
0.06%
+53.8%
Q4 2019$853,000
+94.3%
19,948
+56.4%
0.04%
+550.0%
Q1 2017$439,00012,7570.01%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Sio Capital Management, LLC 563,200$16,243,0009.48%
Avoro Capital Advisors LLC 1,486,460$42,870,0008.66%
Baker Brothers Advisors 25,819,768$744,642,0007.30%
SECTORAL ASSET MANAGEMENT INC 1,176,543$33,932,0003.76%
HARVEY CAPITAL MANAGEMENT INC 251,825$7,262,0003.38%
ACUTA CAPITAL PARTNERS, LLC 300,000$8,652,0003.22%
Palo Alto Investors LP 1,532,030$44,184,0002.52%
Ghost Tree Capital, LLC 350,000$10,094,0002.43%
EMORY UNIVERSITY 76,121$2,195,0002.16%
WEATHERBIE CAPITAL, LLC 576,784$16,634,0002.09%
View complete list of ACADIA PHARMACEUTICALS INC shareholders